Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NL-OMON31039Not yet recruiting
Open-label trial of letrozole and estradiol in obesity (2 arms), sponsored by Vrije University Medical Center. Primary endpoint: Hormone measurements before each estradiol dose change and at study end. Planned start Jan 2008; status: not yet recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NL-OMON31039.